AU Stock MarketDetailed Quotes

NEU Neuren Pharmaceuticals Ltd

Watchlist
  • 13.320
  • +0.080+0.60%
20min DelayMarket Closed Dec 13 16:00 AET
1.73BMarket Cap11.08P/E (Static)

About Neuren Pharmaceuticals Ltd Company

Neuren Pharmaceuticals Ltd is a biopharmaceutical company, which engages in the development of new therapies for brain injury, neurodevelopment disorders. Its drugs target symptoms resulting from acute traumatic brain injury, as well as symptoms of chronic conditions, such as Rett syndrome and Fragile X syndrome. The Group has two reportable operating segments, Commercial Products and Research and Development. It derives maximum revenue from Commercial Products.

Company Profile

SymbolNEU
Company NameNeuren Pharmaceuticals Ltd
Founded2004
MarketASX
Employees11
Fiscal Year Ends12-31
Address697 Burke Road Suite 201
CityMelbourne
CountryAustralia
Zip Code3124
Phone+61 390920480
Websitehttps://www.neurenpharma.com
Share RegistryLINK MARKET SERVICES LIMITED Tower 4, 727 Collins Street, DOCKLANDS, VIC, AUSTRALIA, 3008 1300 554 474

Company Executives

  • Name
  • Position
  • Salary
  • Jonathan Pilcher
  • Director, Chief Executive Officer and Managing Director
  • --
  • Patrick Donald Davies, M.B.A.
  • Non-Executive Chairman of the Board
  • --
  • Dianne Angus
  • Independent Director
  • --
  • Joe Basile
  • Independent Director
  • --
  • Dr. Trevor Scott
  • Independent Director
  • --
  • Dr. Jenny Harry
  • Independent Director
  • --
Trending AU Stocks
ASX High Dividend ASX High Dividend
Symbol Mini Chart % Chg
Westpac Banking Corp
WBC
+0.66%
Woodside Energy Group Ltd
WDS
+0.46%
CommBank
CBA
+0.44%
ANZ Group Holdings Ltd
ANZ
+0.03%
National Australia Bank Ltd
NAB
-0.13%

Unlock the Full List